ID – 1724
REAL-WORLD SAFETY PROFILE OF TWICE-DAILY DEFERIPRONE FOR IRON OVERLOAD IN US PATIENTS WITH THALASSEMIA, SICKLE CELL DISEASE OR OTHER ANEMIAS
a New York-Presbyterian Hospital-Weill Cornell Medical Center, United States
b UCSF Benioff Children’s Hospital Oakland, United States
c Northwell Health New York, Cohen Children’s Medical Center New York, United States
d Department of Medicine, Division of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, United States
e Chiesi Canada Corp., United States
f Chiesi Brasil, São Paulo, SP, Brazil
g Children’s Hospital Los Angeles, United States
